The structure-guided design of norovirus 3CL protease inhibitors was performed. Potency was modulated by exploiting interactions with the S4 subsite of the enzyme. X-ray crystal structures of enzyme-inhibitor complexes confirmed the mechanism. The inhibitor design rationale was validated by x-ray crystallographic studies.